Closeness of Partners During Cancer May Help Keep Symptom Burden Low

Article

Partners who remain close during cancer-related discussions may protect the person with the disease from experiencing increased symptom burden.

Partners who remain close during cancer-related discussions may protect the person with the disease from experiencing increased symptom burden, according to study findings presented during the American Society of Clinical Oncology (ASCO) Palliative and Supportive Care in Oncology Symposium.

Researchers from The University of Texas MD Anderson Cancer Center in Houston examined attachment style of patients with metastatic non-small cell lung cancer, who often have a poor prognosis, and their partners.

Attachment style dates back to the late 1960s and describes the ways in which children respond when they are separated from their primary caregiver. It is often developed in the first year of life, lead author Kathrin Milbury, Ph.D., an associate professor at MD Anderson, explained in an interview with CURE. Children can be securely attached, anxiously attached or avoidantly attached. If a child is securely attached, it means they are happy when reunited. For those who are anxious, they may become clingy or overexcited. And children who are avoidant may give a caregiver the cold shoulder.

“This very early attachment style gets hardwired into our brains and as people grow up throughout their adulthood this attachment paradigm shows up most commonly in romantic relationships,” Milbury said. “In times of stress we can either solicit support from our partner and feel good about receiving support, avoid it and don’t depend on anyone or the anxious ones become preoccupied with the partner not loving them, the partner leaving them, and they don’t feel secure in their relationship.”

Researchers asked patients and their partners — the median time together was 27 years — to compete surveys that assessed attachment and emotional closeness during cancer-related discussions. In addition, patients self-reported symptom burden on a 13-point scale and how it affected their daily living. Physical symptoms were low; however, sadness and distress were most common regarding psychological symptoms.

Just over half (51 percent) of patients were women and the majority (80 percent) were white. The median age was 65 years old. Partners were also mainly women (51 percent) and white (68 percent). The median age was 64 years old.

Researchers found that patients who had high attachment avoidance had significantly higher cancer symptoms compared with patients who had secure attachment. In addition, symptoms were also significantly higher for patients whose partners reported low closeness compared with those who reported high closeness during cancer-related discussions.

“The good news is that (people) can be rewired so to speak,” Milbury said. “Usually, it’s through counseling or support of a supportive partner. If their partner can maintain intimacy as they are discussing cancer-related concerns, it protects the patient from the consequences of an avoidant attachment style. The partner can function almost as a buffer.”

It is important for patients and partners to view cancer as something that affects the entire family, explained Milbury. “We see that especially male patients engage in protective buffering and they don’t want to talk about their worries because they don’t want to burden their family,” she said. “While that is well-intended, it hinders closeness and emotional intimacy. Do not be afraid to share your worries and concerns. And if someone shares worries and concerns, be there and listen. Don’t try to fix it.”

Related Videos
For patients with cancer, the ongoing chemotherapy shortage may cause some anxiety as they wonder how they will receive their drugs. However, measuring drugs “down to the minutiae of the milligrams” helped patients receive the drugs they needed, said Alison Tray. Tray is an advanced oncology certified nurse practitioner and current vice president of ambulatory operations at Rutgers Cancer Institute in New Jersey.  If patients are concerned about getting their cancer drugs, Tray noted that having “an open conversation” between patients and providers is key.  “As a provider and a nurse myself, having that conversation, that reassurance and sharing the information is a two-way conversation,” she said. “So just knowing that we're taking care of you, we're going to make sure that you receive the care that you need is the key takeaway.” In June 2023, many patients were unable to receive certain chemotherapy drugs, such as carboplatin and cisplatin because of an ongoing shortage. By October 2023, experts saw an improvement, although the “ongoing crisis” remained.  READ MORE: Patients With Lung Cancer Face Unmet Needs During Drug Shortages “We’re really proud of the work that we could do and achieve that through a critical drug shortage,” Tray said. “None of our patients missed a dose of chemotherapy and we were able to provide that for them.” Tray sat down with CURE® during the 49th Annual Oncology Nursing Society Annual Congress to discuss the ongoing chemo shortage and how patients and care teams approached these challenges. Transcript: Particularly at Hartford HealthCare, when we established this infrastructure, our goal was to make sure that every patient would get the treatment that they need and require, utilizing the data that we have from ASCO guidelines to ensure that we're getting the optimal high-quality standard of care in a timely fashion that we didn't have to delay therapies. So, we were able to do that by going down to the minutiae of the milligrams on hand, particularly when we had a lot of critical drug shortages. So it was really creating that process to really ensure that every patient would get the treatment that they needed. For more news on cancer updates, research and education, don’t forget to subscribe to CURE®’s newsletters here.
Yuliya P.L Linhares, MD, an expert on CLL
Yuliya P.L Linhares, MD, and Josie Montegaard, MSN, AGPCNP-BC, experts on CLL
Image of a man with a beard.
Image of a man with gray facial hair and a navy blue suit with a light orange tie.
Image of a woman with black hair.
Related Content